Chris Churchill serves as of President of National Cardiovascular Partners and President of Spectra Laboratories, dual roles he assumed in 2022. Chris also serves as the Senior Vice President of Corporate Development and Strategy, which includes acquisitions, for Fresenius Medical Care’s services businesses, where he previously held a number of different roles including leading inpatient services, home therapies, marketing, product management and customer experience.
Chris began his career in investment banking, after which he joined Iron Mountain, an enterprise information management services company, where he led two of their highest growth business units. He holds a Bachelor of Arts degree in Economics from Princeton University and an MBA from Harvard Business School.
